ADAPT: Managed local follow-up of long-term cancer survivors

Even when a person has managed to beat cancer, it is an unfortunate fact that complications can arise years in the future due to the treatments they received for their cancer. There is therefore an urgent need to address this issue with measures to track and trace cancer treatment complications down the line.

A strategy has been developed for managing cancer patients 5+years from treatment when the risk of cancer recurrence is low but patients are at risk of other multiple health issues because of the effects of their previous treatment of cancer (i.e. late treatment toxicity).

The University of Manchester’s intervention, called ADAPT, provides patients and GPs with individualised information about diagnosis, treatment, possible late toxicities and how these can be recognised, mitigated and managed.

So far 780 patients have been ADAPTed at the Christie Hospital in Manchester with very good feedback from patients and GPs. The team estimate that for this number of patients ADAPT will save 780 appointments, £117,000 and 1 working year of time per annum recurrently.

From April 2018 commissioners at the Christie have provided funding for infrastructure support based on 33% of the savings made. ADAPT has been integrated into PINGR (a GP electronic patient record) and implemented across Salford.

The team, lead by Professor John Radford, are now creating a digital platform (eADAPT) in collaboration with Professor Niels Peek and Stephen Campbell at The University of Manchester. This will provide a patient-facing website/app and be widely applicable.

They are also planning to integrate other interventions that they have developed into eADAPT, such as an intervention to monitor specific risk factors in young women who have previously been treated for breast cancer, and an intervention to monitor thyroid function post-radiotherapy.

 

For more information, please contact:

Ian Stephenson
ian.stephenson@uominnovationfactory.com
+44 (0)7795 092 498 (mobile)